Multiple Assemblies exist for SMTL entry 4fw3
Crystal Structure of the LpxC in complex with N-[(2S)-3-AMINO-1-(HYDROXYAMINO)-1-OXOPROPAN-2-YL]-4-(4-PHENYLBUTA-1,3-DIYN-1-YL)BENZAMIDE inhibitor; X-RAY DIFFRACTION 2.35 Å

	SMTL ID 4fw3.1 Ligands ZINC ION; N-[(2S)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide; GLYCEROL Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer
	SMTL ID 4fw3.2 Ligands ZINC ION; N-[(2S)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer
	SMTL ID 4fw3.3 Ligands ZINC ION; N-[(2S)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer
	SMTL ID 4fw3.4 Ligands ZINC ION; N-[(2S)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-phenylbuta-1,3-diyn-1-yl)benzamide; GLYCEROL Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer